New in CME Courses: Non-Small Cell Lung Cancer: Optimizing Systemic Therapy Options Beyond the 1st Line

Target audience:  Oncologists, oncology nurses, pathologists, radiologists, pharmacists, and other healthcare practitioners who care for patients with lung cancer. Disease Progression After First Line Therapy Patients refractory to first-line therapy have a particularly poor prognosis and present Read More

New in CME courses: Experts in the Hot Seat: Navigating PCSK9 Inhibitor Prescribing in Persistent Elevated LDL-C

Target audience:  Lipidologists, endocrinologists, cardiologists, nurse practitioners, physician assistants, registered dietitians, advanced practice registered nurses, registered nurses, and pharmacists who are members of the NLA, as well as a national cohort of providers who manage patients with Read More

New in CME courses: Targeting Molecular Mechanisms in Patients with Metastatic Breast Cancer: Inhibiting Estrogen Receptor-Induced Proliferation

Target audience:  Oncologists, surgeons, ONS nurses, and other healthcare providers involved in the treatment of patients with breast cancer. The complexity of breast cancer continues to be revealed Ten-year breast-cancer (BC) mortality rates are reduced by a third with hormone therapy, meaning Read More